| |
Main
Date: 16 Aug 2007 03:07:20
From: Mark VandenBerghe
Subject: Proof that this was a "cleaner" Tour
|
WSJ NEWS ALERT: Amgen Plans to Cut Work Force Amid Slump in Aranesp Drug
from The Wall Street Journa
Aug. 15, 2007
Amgen said it will cut staff by up to 14%, slash capital expenses by $1.9
billion, and close some production facilities in an effort to offset
slumping sales of its top-selling anemia drug Aranesp. The restructuring --
unprecedented in the biotech giant's 27-year history -- will trigger $600
million to $700 million in pre-tax charges. Amgen also cut its 2007 earnings
estimate, previously $4.28 a share, down to a range of $4.13 to $4.23,
compared with $3.90 a year earlier.
FOR MORE INFORMATION, see:
http://wsj.com/article/0,,SB118720529438898746,00.html?mod=djemalert
|
|
| |
Date: 16 Aug 2007 14:24:43
From: Dan Connelly
Subject: Re: Proof that this was a "cleaner" Tour
|
Mark VandenBerghe wrote:
> WSJ NEWS ALERT: Amgen Plans to Cut Work Force Amid Slump in Aranesp Drug
>
They should advertise in:
http://www.geezerjock.com/public/335.cfm
|
| | |
Date: 16 Aug 2007 18:56:24
From: Tom Kunich
Subject: Re: Proof that this was a "cleaner" Tour
|
"Dan Connelly" <d_j_c_o_n_n_e_l@y_a_h_o_o_._c_o_m > wrote in message
news:L6Zwi.27907$RX.10681@newssvr11.news.prodigy.net...
> Mark VandenBerghe wrote:
>> WSJ NEWS ALERT: Amgen Plans to Cut Work Force Amid Slump in Aranesp Drug
>>
>
> They should advertise in:
> http://www.geezerjock.com/public/335.cfm
Dsn, you're beginning to have some serious problems. I suggest you aren't
winning because you're getting older.
|
|
